Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

836 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.
Sato S, Hasegawa M, Takehara K. Sato S, et al. Among authors: takehara k. J Dermatol Sci. 2001 Oct;27(2):140-6. doi: 10.1016/s0923-1811(01)00128-1. J Dermatol Sci. 2001. PMID: 11532378
Clinical evaluation of scleroderma spectrum disorders using a points system.
Ihn H, Sato S, Tamaki T, Soma Y, Tsuchida T, Ishibashi Y, Takehara K. Ihn H, et al. Among authors: takehara k. Arch Dermatol Res. 1992;284(7):391-5. doi: 10.1007/BF00372068. Arch Dermatol Res. 1992. PMID: 1288419
Alteration of the chemotactic response of human skin fibroblasts to PDGF by growth factors.
Soma Y, Takehara K, Ishibashi Y. Soma Y, et al. Among authors: takehara k. J Dermatol. 1992 Nov;19(11):654-6. doi: 10.1111/j.1346-8138.1992.tb03752.x. J Dermatol. 1992. PMID: 1293148 No abstract available.
Skin distribution and differential expression of transforming growth factor beta 1 and beta 2.
Falanga V, Gerhardt CO, Dasch JR, Takehara K, Ksander GA. Falanga V, et al. Among authors: takehara k. J Dermatol Sci. 1992 May;3(3):131-6. doi: 10.1016/0923-1811(92)90026-8. J Dermatol Sci. 1992. PMID: 1498091
Early detection of scleroderma spectrum disorders in patients with Raynaud's phenomenon.
Takehara K, Soma Y, Ishibashi Y. Takehara K, et al. Dermatologica. 1991;183(3):164-8. doi: 10.1159/000247662. Dermatologica. 1991. PMID: 1743381
Epidemiological study of patients with systemic sclerosis in Tokyo.
Tamaki T, Mori S, Takehara K. Tamaki T, et al. Among authors: takehara k. Arch Dermatol Res. 1991;283(6):366-71. doi: 10.1007/BF00371817. Arch Dermatol Res. 1991. PMID: 1796818
Response of scleroderma fibroblasts to various growth factors.
Takehara K, Soma Y, Igarashi A, Kikuchi K, Moro A, Ishibashi Y. Takehara K, et al. Arch Dermatol Res. 1991;283(7):461-4. doi: 10.1007/BF00371783. Arch Dermatol Res. 1991. PMID: 1801656
[The titers and complement-activating abilities of anticentromere antibody in systemic sclerosis, other connective tissue diseases, and other related conditions].
Sato S, Takehara K, Ishibashi Y. Sato S, et al. Among authors: takehara k. Nihon Hifuka Gakkai Zasshi. 1991 Feb;101(2):97-104. Nihon Hifuka Gakkai Zasshi. 1991. PMID: 2072581 Japanese.
The effects of scleroderma sera on endothelial cell survival in vitro.
Etoh T, Igarashi A, Iozumi K, Ishibashi Y, Takehara K. Etoh T, et al. Among authors: takehara k. Arch Dermatol Res. 1990;282(8):516-9. doi: 10.1007/BF00371946. Arch Dermatol Res. 1990. PMID: 2082833
Longitudinal study of patients with anticentromere antibody.
Takehara K, Soma Y, Igarashi A, Kikuchi K, Tamaki T, Ishibashi Y. Takehara K, et al. Dermatologica. 1990;181(3):202-6. doi: 10.1159/000247924. Dermatologica. 1990. PMID: 2135387
836 results
Jump to page
Feedback